DoD Lupus Research Program Funding Opportunities
The FY22 LRP funding opportunity announcements for the following award mechanisms will be posted on the Grants.gov website.
Applications submitted to the FY22 LRP Idea and Impact Awards must address one or more of the following Focus Areas:
- Understanding how lupus disease heterogeneity impacts risk of disease, disease presentation, clinical course, and outcomes; using a diverse range of research disciplines including, but not limited to, biopsychosocial studies, personalized medicine, variation in treatment studies, health economics, socioeconomic studies, environmental studies, and epidemiological studies
- Understanding the biological mechanisms of lupus disease including, but not limited to, studies of informative/rare patients
- Determining the pathobiology of end organ injury related to lupus disease in target human tissues
- Improving quality of life for individuals living with lupus including, but not limited to, addressing social determinants of health, access to healthcare resources, outcomes research, patient-reported outcomes, symptom and disease control, comparative effectiveness research, and issues and challenges that, when addressed, make day-to-day living with lupus easier and life more fulfilling
- Understanding the underlying genetic and epigenetic components and gene-environment interactions of lupus and how they may relate to clinical disease characteristics, variations, disparities and differences in response to therapies using functional genomic studies
- Innovative health care delivery models improving outcomes for lupus (Impact Award only)
Applications submitted to the FY22 LRP Transformative Vision Award must address one of the following Focus Areas:
- Innovative health care delivery models improving outcomes for lupus
- Design and implement an intervention either at the individual and/or healthcare system level to improve the quality of life for individuals living with lupus. Example interventions include, but are not limited to, access to healthcare resources, outcomes research, symptom and disease control, comparative effectiveness research, and issues and challenges that, when addressed, make day-to-day living with lupus easier and life more fulfilling
Idea Award – Letter of Intent due August 16, 2022
All investigators at or above the level of postdoctoral fellow (or equivalent)
- · Supports innovative, high-risk/high-reward research that could ultimately lead to a critical discovery or major advancement relevant to lupus.
- · Emphasis on innovation.
- · Must address one of the Fiscal Year 2022 (FY22) LRP IA Focus Areas.
- · Clinical trials are not allowed.
- · Preliminary data are not required.
- · The maximum allowable funding for the entire period of performance is $300,000 for total costs (direct plus indirect costs).
- · The maximum period of performance is 2 years.
Impact Award – Letter of Intent due August 16, 2022
Independent investigators at or above the level of Assistant Professor (or equivalent)
- · Supports high-risk/high-reward research which, if successfully addressed, has the potential to make a major impact in lupus research.
- · Emphasis on impact.
- · Must address one of the FY22 LRP IPA Focus Areas.
- · Clinical trials are not allowed.
- · Preliminary data are encouraged but not required.
- · The maximum allowable funding for the entire period of performance is $750,000 for total costs (direct plus indirect costs).
- · The maximum period of performance is 4 years.
Transformative Vision Award – Letter of Intent due August 16, 2022
Independent investigators at or above the level of Assistant Professor (or equivalent)
- · Supports research that will have an intervention at the individual and/or healthcare system level, which will result in near-term impact on the health-related quality of life of persons living with lupus.
- · Emphasis on near-term impact to quality of life.
- · Must address the FY22 LRP TVA Focus Areas.
- · Human subject research and clinical trials are allowed.
- · Preliminary data are required.
- · Animal studies are not allowed.
- · Partnering Principal Investigator (PI) Option allows one Initiating Investigator and a maximum of two Partnering PIs.
- · The research team must include one or more Consumer Advocate(s).
- · The maximum allowable funding for the entire period of performance is $2.5 million for total costs (direct plus indirect).
- · The maximum period of performance is 4 years.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final funding opportunity announcements available for downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRDC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the LRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Help Desk
301-682-5507
For more information, please contact Jill Sherman, International Research Facilitator, at intl.research@lakeheadu.ca .